Doliver Advisors LP Sells 58 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Doliver Advisors LP decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,476 shares of the medical equipment provider’s stock after selling 58 shares during the quarter. Doliver Advisors LP’s holdings in Intuitive Surgical were worth $1,814,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Capital Market Strategies LLC increased its stake in Intuitive Surgical by 7.8% in the 4th quarter. Capital Market Strategies LLC now owns 1,237 shares of the medical equipment provider’s stock valued at $646,000 after buying an additional 90 shares during the last quarter. Nordea Investment Management AB increased its position in shares of Intuitive Surgical by 31.7% during the fourth quarter. Nordea Investment Management AB now owns 43,200 shares of the medical equipment provider’s stock valued at $22,632,000 after acquiring an additional 10,405 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Intuitive Surgical by 10.0% during the fourth quarter. GAMMA Investing LLC now owns 5,597 shares of the medical equipment provider’s stock worth $2,921,000 after acquiring an additional 507 shares during the period. Versant Capital Management Inc boosted its position in Intuitive Surgical by 27.4% in the fourth quarter. Versant Capital Management Inc now owns 688 shares of the medical equipment provider’s stock worth $359,000 after purchasing an additional 148 shares during the last quarter. Finally, SMART Wealth LLC bought a new position in Intuitive Surgical in the 3rd quarter valued at $290,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, December 11th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Robert W. Baird increased their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Finally, Leerink Partners boosted their target price on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Trading Up 1.0 %

Shares of NASDAQ:ISRG traded up $5.56 on Monday, reaching $540.86. 585,071 shares of the company traded hands, compared to its average volume of 895,106. The stock has a market capitalization of $192.64 billion, a P/E ratio of 86.96, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. The business’s 50-day simple moving average is $532.76 and its 200 day simple moving average is $491.43. Intuitive Surgical, Inc. has a 52 week low of $324.12 and a 52 week high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock valued at $25,012,927 in the last 90 days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.